FDA Adverse Event Malfunction Summary report: N

MICROSTREP PLUS TYPE 1 PANELS

MDR report key: 3888424 · Received April 1, 2014

Report

Report Number
2919016-2014-00016
Event Type
Malfunction
Date Received
April 1, 2014
Date of Event
March 7, 2014
Report Date
March 7, 2014
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
LTT
Removal / Correction Number
Z-1272-2013
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

SIEMENS HAD CONDUCTED A FIELD CORRECTION, (B)(4), FOR FALSE SKIPPED WELLS AND FALSE SUSCEPTIBLE MISREADS WITH S. AGALACTIAE AFFECTING MULTIPLE ANTIMICROBIAL AGENTS ON MICROSCAN MICROSTREP PLUS TYPE 1 PANELS (B1027-201), MICROSTREP PLUS TYPE 5 PANELS (B1016-905), MICROFAST TYPE 5J PANELS (J1016-83) AND MICROFAST TYPE 7J PANELS (J1016-84). THE CUSTOMER LETTER STATED RESULTS SHOULD BE VISUALLY VERIFIED FOR S. AGALACTIAE ISOLATES ON THE ABOVE PANEL TYPES. ADDITIONALLY ALL SUBSEQUENT LOTS WERE MANUFACTURED WITH UPDATED INFO ON THIS LIMITATION. SIEMENS CONFIRMED THAT THIS CUSTOMER RECEIVED THE INITIAL CUSTOMER NOTIFICATION ASSOCIATED WITH FDA RECALL (B)(4) AND THAT THE LOT WAS MANUFACTURED WITH THE UPDATED INFO (CONFIRMED THROUGH A REVIEW OF THE MANUFACTURING RECORDS).

Description of Event or Problem · 1

A CUSTOMER COMPLAINT WAS RECEIVED FOR S. AGALACTIAE ISOLATE WITH SUSCEPTIBLE RESULTS FOR ERYTHROMYCIN USING A WALKAWAY BUT VISUALLY THE RESULTS WERE RESISTANT. PANELS WERE VISUALLY VERIFIED AND THE CORRECT "RESISTANT" RESULTS WERE REPORTED TO THE PHYSICIAN. THERE WAS NO ADVERSE IMPACT TO PATIENT TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
194298 MICROSTREP PLUS TYPE 1 PANELS MICROSTREP PLUS TYPE 1 LTT SIEMENS HEALTHCARE DIAGNOSTICS INC. 2014-08-05

Patients

Seq Age Sex Outcome Treatment
1